JNJ logo

JNJ Johnson & Johnson

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$270.47
+3.33 (+1.25%)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a p…

Market Cap: $651.11Bwww.jnj.com

Price

$270.47-0.98%
$248.61$260.99$273.37$285.75
Aug 25Nov 20

Social Signal Score

55
5d
50
30 mentions
-3.0%
30d
53
150 mentions
+2.5%
60d
57
318 mentions
+0.5%
90d
59
433 mentions
-0.9%
news: 177 · 4chan: 24 · marketaux: 70 · rss: 151 · podcast: 9 · finnhub: 2

Analyst Ratings

40 analysts
Buyconsensus
Strong Buy 0Buy 21Hold 16Sell 3Strong Sell 0
Avg price target$285.31+5.5%
Low $260Median $281High $320
Current Consensus

52-week range

$199.96$285.75
Last close
$270.47
Off 52w high
-5.3%
200-day average
$250.83
vs 200-day
+7.8%

Revenue

$25.40B+40.28%
$17.77B$20.31B$22.85B$25.40B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$10.80
$10.72–$10.84
17 analysts
FY2026
$11.11+3% YoY
$11.04–$11.20
12 analysts
FY2027
$11.57+4% YoY
$10.81–$12.34
12 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Joaquin Duato
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
141,700
Beta
0.23
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
5.39
www.jnj.com